These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Racemic therapeutic agents; problems concerning medical ethics and registration]. Bennebroek Gravenhorst J; Engberts DP; Vermeij P Ned Tijdschr Geneeskd; 1991 Apr; 135(16):722-3. PubMed ID: 2038400 [No Abstract] [Full Text] [Related]
5. [Relationship between chemical structure and pharmacodynamic activity]. Tronchet JM Pharm Acta Helv; 1973; 48(8):482-8. PubMed ID: 4766789 [No Abstract] [Full Text] [Related]
6. [Stereochemistry and drug effects--a neglected field of knowledge]. Reis M; Kugelberg FC; Carlsson B; Josefsson M; Waldeck B Lakartidningen; 2006 Apr 26-May 2; 103(17):1305-6, 1309-11. PubMed ID: 16708858 [No Abstract] [Full Text] [Related]
7. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States. Miller CP; Ullrich JW Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591 [TBL] [Abstract][Full Text] [Related]
8. Chirality and drugs in clinical practice and its ethical aspect. Banerjee M; Biswas I; Halder S J Indian Med Assoc; 2009 Jan; 107(1):41-2. PubMed ID: 19588688 [TBL] [Abstract][Full Text] [Related]
9. [Chiral compounds and their pharmacologic effects]. Slováková A; Hutt AJ Ceska Slov Farm; 1999 May; 48(3):107-12. PubMed ID: 10422348 [TBL] [Abstract][Full Text] [Related]
10. [Pharmacology and ethics]. Sancipriano M Minerva Nipiol; 1966; 16(6):159-64. PubMed ID: 5998410 [No Abstract] [Full Text] [Related]
12. Does the left hand know what the right hand is doing? or Clinical pharmacology: the use of optically pure (R or S) forms of chiral drugs rather than racemic mixtures. Howard-Lock HE; Lock CJ; Kean WF J Rheumatol; 1986 Dec; 13(6):1000-3. PubMed ID: 3560086 [No Abstract] [Full Text] [Related]
13. Emergence of a single solid chiral state from a nearly racemic amino acid derivative. Noorduin WL; Izumi T; Millemaggi A; Leeman M; Meekes H; Van Enckevort WJ; Kellogg RM; Kaptein B; Vlieg E; Blackmond DG J Am Chem Soc; 2008 Jan; 130(4):1158-9. PubMed ID: 18173274 [No Abstract] [Full Text] [Related]
14. Asymmetric synthesis of active pharmaceutical ingredients. Farina V; Reeves JT; Senanayake CH; Song JJ Chem Rev; 2006 Jul; 106(7):2734-93. PubMed ID: 16836298 [No Abstract] [Full Text] [Related]
15. International Symposium on Clinical Pharmacology. Introduction. Smahel O Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):3-5. PubMed ID: 4924327 [No Abstract] [Full Text] [Related]
16. [Problems posed by stereochemistry in therapeutics]. Ariëns EJ Arch Farmacol Toxicol; 1986 Apr; 12(1):3-27. PubMed ID: 3740967 [No Abstract] [Full Text] [Related]
17. Recent progress in enzymatic resolution and desymmetrization of pharmaceuticals and their intermediates. Pesti JA; DiCosimo R Curr Opin Drug Discov Devel; 2003 Nov; 6(6):884-901. PubMed ID: 14758759 [TBL] [Abstract][Full Text] [Related]
19. [Nontraditional areas for the use of pharmacologic preparations based on research on the molecular mechanisms of their action]. Piruzian LA; Mikhaĭlovskiĭ EM; Dement'ev VA Izv Akad Nauk SSSR Biol; 1989; (6):838-42. PubMed ID: 2695546 [TBL] [Abstract][Full Text] [Related]
20. Structure-based organic synthesis of drug prototypes: a personal odyssey. Hanessian S ChemMedChem; 2006 Dec; 1(12):1301-30. PubMed ID: 17091524 [No Abstract] [Full Text] [Related] [Next] [New Search]